---

Philip J. Rosenfeld

Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

Rosenfeld, a retina specialist with a particular interest in the treatment and study of macular degeneration, has been a principal investigator of many of the pivotal clinical trials of anti-VEGF agents (and photodynamic therapy) for the treatment of retinal disease. Of his research into the ophthalmic application of bevacizumab, a nominator said, “Rosenfeld is the pioneer in its use. Now the most commonly used anti-VEGF in the world, its low cost and benefits have provided vision-saving therapy to millions.” He has received the AAO’s Senior Achievement and Secretariat Awards, the Macula Society’s Richard and Hinda Rosenthal Foundation Award, the Heed Award, the ASRS’ Founders Award and the J. Donald Gass Award from the Retina Society amongst many.

---

Part of the Power List 2016

100 reasons to be proud

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016